PDSB
PDSB
NASDAQ · Biotechnology

Pds Biotechnology Corp

$0.72
+0.02 (+3.59%)
As of Feb 8, 2:20 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 7.82M 7.64M 6.13M
Net Income -1,043,017 -954,590 -792,337
EPS
Profit Margin -13.3% -12.5% -12.9%
Rev Growth -3.5% +15.6% +20.8%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 21.34M 20.87M 17.34M
Total Equity 15.18M 15.06M 16.26M
D/E Ratio 1.41 1.39 1.07
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -1,028,959 -906,364 -702,614
Free Cash Flow -801,636 -705,541 -523,657